MYC DNA Methylation in Prostate Tumor Tissue Is Associated with Gleason Score.

Area of Science:

• Epigenetics
• Cancer Genetics
• Molecular Biology

Background:

• Chromosome 8q24 is a key region for prostate cancer genetic susceptibility.
• Epigenetic modifications, such as DNA methylation, are increasingly implicated in cancer development.
• The MYC oncogene is frequently dysregulated in various cancers, including prostate cancer.

Purpose of the Study:

• To investigate the association between MYC DNA methylation at chromosome 8q24 and prostate tumor aggressiveness.
• To explore the functional role of MYC DNA methylation by incorporating RNA expression data.
• To compare MYC DNA methylation patterns in tumor versus normal prostate tissue and across different Gleason scores.

Main Methods:

• Analysis of radical prostatectomy tissue from 100 prostate cancer patients (50 Caucasian, 50 African American).
• Quantification of MYC DNA methylation at six CpG sites (exon 3 to 3' UTR) and assessment of tumor aggressiveness (Gleason score 6 vs. 7).
• Integration of RNA expression data for MYC and PRNCR1, and comparison with The Cancer Genome Atlas data.

Main Results:

• MYC DNA methylation was significantly lower in prostate tumor tissue compared to paired normal tissue across all analyzed CpG sites.
• Tumors with higher Gleason scores (GS 7) exhibited significantly lower methylation at three MYC exon 3 CpG sites compared to lower-grade tumors (GS 6).
• MYC DNA methylation levels did not correlate with MYC expression but showed an inverse association with PRNCR1 expression.

Conclusions:

• Prostate tumor hypomethylation of MYC exon 3 is associated with increased tumor aggressiveness.
• Epigenetic alterations in the 8q24 region, specifically involving MYC, may contribute to prostate cancer progression.
• The inverse relationship between MYC methylation and PRNCR1 expression warrants further investigation into their functional interplay in prostate cancer.